Cart summary

You have no items in your shopping cart.

Nedosiran

SKU: orb1691045

Description

Nedosiran is a GalNAc-conjugated double-stranded RNAi therapeutic targeting lactate dehydrogenase (LDH) for primary hyperoxaluria. It is investigated in preclinical and clinical studies for reducing oxalate production, offering a potential treatment for patients with PH and ESRD.

Research Area

Metabolism Research

Images & Validation

Key Properties

CAS Number2266591-83-5
TargetDehydrogenase

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Nedosiran sodium [orb1983293]

    2247026-22-6

    5 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Nedosiran (orb1691045)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%